Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00805285 · ClinicalTrials.gov registry record · Phase 2
The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis
A Phase 2 study, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT00805285 is a Phase 2 study that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 1 participants.
The verdict
NCT00805285, a Phase 2 study, was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if the combination of oral budesonide and rectal hydrocortisone improves symptoms in patients with active ulcerative colitis. Also, we would like to determine if oral budesonide and rectal hydrocortisone has fewer and less severe side effects compared to standard steroids (prednisone).
Interventions
- DRUG Combination Oral Budesonide and Rectal Hydrocortisone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00805285
The ClinicalTrials.gov registry entry for NCT00805285 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Combination Oral Budesonide and Rectal Hydrocortisone is the first listed.
NCT00805285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00805285 about?
NCT00805285 is a clinical study titled "The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis". The purpose of this study is to evaluate if the combination of oral budesonide and rectal hydrocortisone improves symptoms in patients with active ulcerative colitis. Also, we would like to determine if oral budesonide and rectal hydrocortisone has fewer and less severe side effects compared to stan...
What is the current status of trial NCT00805285?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2008-10. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00805285?
The interventions under investigation include: Combination Oral Budesonide and Rectal Hydrocortisone (DRUG).
Who is sponsoring clinical trial NCT00805285?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.